I think that you are right about the sector getting hammered. But if you look at the results of Pepper and Solvar they tell a very different story to CCV.
pepper has declining revenue, margins and profits. And Solnar also has issues like slow revenue growth relative to loan book growth. Decline EPS and losses at NPAT .
Half year profits in Feb (hopefully show strong profit growth) should be a catalyst for a rerating of this stock and will separate the from the pack.
fingers crossed.
I think that you are right about the sector getting hammered....
Add CCV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $136.4M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.5¢ | $56.74K | 257.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 45500 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 86484 | 6 |
View Market Depth
| Last trade - 11.17am 02/10/2024 (20 minute delay) ? |
| CCV (ASX) Chart |